RBBP4 and pancreatic neoplasm: Here, we examined the hypothesis that miR-6794-3p-mediated inhibition of RBBP4 enhances histone H3 acetylation, leading to increased expression of epithelial markers and, consequently, inhibition of pancreatic cancer cell invasion and migration.